Life ScienceCompany
Global Stem cell Technology Ownership
Who owns Global Stem cell Technology?
Global Stem cell Technology is owned by Boehringer Ingelheim. It was acquired on July 27, 2020.
Global Stem cell Technology Business Overview
Where is Global Stem cell Technology headquartered?
Global Stem cell Technology is headquartered in Evergem, Belgium.
What sector is Global Stem cell Technology in?
Global Stem cell Technology is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.